{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:40:59Z","timestamp":1787985659109,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T00:00:00Z","timestamp":1334188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-230x-12-32","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T18:14:16Z","timestamp":1334254456000},"source":"Crossref","is-referenced-by-count":37,"title":["Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial"],"prefix":"10.1186","volume":"12","author":[{"given":"Mostafa","family":"Yakoot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,12]]},"reference":[{"key":"708_CR1","unstructured":"World Health Organization: Hepatitis C. Factsheet No 164 (updated Oct 2000). (accessed 3 Feb 2008), [ http:\/\/www.who.int\/mediacentre\/factsheets\/en\/ ]"},{"issue":"7548","key":"708_CR2","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1136\/bmj.332.7548.1013","volume":"332","author":"K Patel","year":"2006","unstructured":"Patel K, Muir AJ, McHutchison JG: Diagnosis and treatment of chronic hepatitis C infection. BMJ. 2006, 332 (7548): 1013-7. 10.1136\/bmj.332.7548.1013.","journal-title":"BMJ"},{"key":"708_CR3","first-page":"1","volume":"47","author":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease","year":"1998","unstructured":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease: Center for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep. 1998, 47: 1-39.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"708_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1478-3231.2011.02540.x","volume":"31","author":"W Sievert","year":"2011","unstructured":"Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, et al: A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011, 31 (2): 61-80.","journal-title":"Liver Int"},{"key":"708_CR5","first-page":"341","volume":"72","author":"C Hepatitis","year":"1997","unstructured":"Hepatitis C: Global prevalence. Wkly Epidemiol Rec. 1997, 72: 341-344.","journal-title":"Wkly Epidemiol Rec"},{"issue":"3","key":"708_CR6","first-page":"1","volume":"19","author":"Management of hepatitis C","year":"2002","unstructured":"Management of hepatitis C: NIH Consens State Sci Statements. 2002, 19 (3): 1-46.","journal-title":"NIH Consens State Sci Statements"},{"key":"708_CR7","first-page":"4862","volume":"8","author":"T Thevenot","year":"1999","unstructured":"Thevenot T, Regimbeau C, Ratziu V, Leroy V, Opolon P, Poynard T: Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in na\u00efve patients. Viral Hepat. 1999, 8: 4862-","journal-title":"Viral Hepat"},{"key":"708_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1517\/14656566.6.3.399","volume":"6","author":"C Camma","year":"2005","unstructured":"Camma C, Licata A, Cabibbo G, Latteri F, Craxi A: Treatment of hepatitis C: critical appraisal of the evidence. Expert Opin Pharmacother. 2005, 6: 399-408. 10.1517\/14656566.6.3.399.","journal-title":"Expert Opin Pharmacother"},{"key":"708_CR9","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1136\/gut.2005.076646","volume":"55","author":"MP Manns","year":"2006","unstructured":"Manns MP, Wedemeyer H, Cornberg M: Treating viral hepatitis C: efficacy, side effects, and complications. Gut. 2006, 55: 1350-1359. 10.1136\/gut.2005.076646.","journal-title":"Gut"},{"key":"708_CR10","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/hep.22127","volume":"47","author":"SM Kamal","year":"2008","unstructured":"Kamal SM, Nasser IA: Hepatitis C genotype 4: what we know and what we don't yet know. Hepatology. 2008, 47: 1371-83. 10.1002\/hep.22127.","journal-title":"Hepatology"},{"key":"708_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jhep.2004.02.007","volume":"40","author":"S Zeuzem","year":"2004","unstructured":"Zeuzem S, Hultcrantz R, Bourliere M: Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3. J Hepatol. 2004, 40: 993-999. 10.1016\/S0168-8278(04)00060-1.","journal-title":"J Hepatol"},{"key":"708_CR12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jhep.2006.10.016","volume":"46","author":"R Moucari","year":"2007","unstructured":"Moucari R, Ripault MP, Oules V, et al: High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapy. J Hepatol. 2007, 46: 596-604. 10.1016\/j.jhep.2006.10.016.","journal-title":"J Hepatol"},{"key":"708_CR13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0016-5085(98)70284-7","volume":"115","author":"RL Koretz","year":"1998","unstructured":"Koretz RL: Interferon in wonderland. Gastroenterology. 1998, 115: 1027-29.","journal-title":"Gastroenterology"},{"issue":"4","key":"708_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.dld.2006.11.004","volume":"39","author":"F Stickel","year":"2007","unstructured":"Stickel F, Schuppan D: Herbal medicine in the treatment of liver diseases. Dig Liver Dis. 2007, 39 (4): 293-304. 10.1016\/j.dld.2006.11.004.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"708_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1440-1746.1998.01550.x","volume":"3","author":"RG Batey","year":"1998","unstructured":"Batey RG, Bensoussan A, Fan YY, Bollipo S, Hossain MA: Preliminary report of a randomized, double-blind placebo-controlled trial of a Chinese herbal medicine preparation CH-100 in the treatment of chronic hepatitis C. J Gastroenterol Hepatol. 1998, 3 (3): 244-7.","journal-title":"J Gastroenterol Hepatol"},{"key":"708_CR16","first-page":"44","volume":"4","author":"C Wu","year":"1994","unstructured":"Wu C, et al: Thirty-three patients with hepatitis C treated by chinese traditional medicine syndrome differentiation. Chinese Journal of Integrated Traditional and Western Medicine for Liver Diseases. 1994, 4: 44-45.","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine for Liver Diseases"},{"issue":"2","key":"708_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1089-3261(05)70174-4","volume":"5","author":"MR Cohen","year":"2001","unstructured":"Cohen MR: Herbal and complementary and alternative medicine therapies for liver disease. A focus on Chinese traditional medicine in hepatitis C virus. Clin Liver Dis. 2001, 5 (2): 461-78. 10.1016\/S1089-3261(05)70174-4. vii","journal-title":"Clin Liver Dis"},{"key":"708_CR18","first-page":"423","volume":"26","author":"H Suzuki","year":"1984","unstructured":"Suzuki H, et al: Effects of glycyrrhizin on biochemical tests in patients with chronic hepatitis double blind trial. Journal of Asian Medicine. 1984, 26: 423-38.","journal-title":"Journal of Asian Medicine"},{"key":"708_CR19","first-page":"555","volume-title":"Critical Rev Food Sci Nutr","author":"RA Kay","year":"1991","unstructured":"Kay RA: Microalgae as food and supplement. Critical Rev Food Sci Nutr. 1991, CRC Press, USA, 555-73."},{"key":"708_CR20","volume-title":"Evid Based Complement Alternat Med","author":"PD Karkos","year":"2008","unstructured":"Karkos PD, Leong SC, Karkos CD, Sivaji N, Assimakopoulos DA: Spirulina in Clinical Practice: Evidence-Based Human Applications. Evid Based Complement Alternat Med. 2008, doi:10.1093\/ecam\/nen058. PubMed Central PMCID: PMC3136577"},{"issue":"4","key":"708_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0278-6915(96)00000-2","volume":"34","author":"M Salazar","year":"1996","unstructured":"Salazar M, Chamorro GA, Salazar S, Steele CE: Effect of Spirulina maxima consumption on reproduction and peri- and postnatal development in rats. Food Chem Toxicol. 1996, 34 (4): 353-359. 10.1016\/0278-6915(96)00000-2.","journal-title":"Food Chem Toxicol"},{"key":"708_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1023\/A:1007994500084","volume":"9","author":"G Chamorro","year":"1997","unstructured":"Chamorro G, Salazar S, Castillo L: Reproductive and peri- postnatal evaluation of Spirulina maxima in mice. J Appl Phycol. 1997, 9: 107-12. 10.1023\/A:1007994500084.","journal-title":"J Appl Phycol"},{"key":"708_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0378-8741(98)00080-4","volume":"62","author":"M Salazar","year":"1998","unstructured":"Salazar M, Martinez E, Madrigal E, Ruiz LE, Chamorro GA: Subchronic toxicity study in mice fed Spirulina. J Ethnopharmacol. 1998, 62: 235-41. 10.1016\/S0378-8741(98)00080-4.","journal-title":"J Ethnopharmacol"},{"key":"708_CR24","first-page":"27","volume":"5","author":"A Belay","year":"2002","unstructured":"Belay A: The potential application of Spirulina (Arthrospira) as a nutritional and therapeutic supplement in Health management. JANA. 2002, 5: 27-48.","journal-title":"JANA"},{"key":"708_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1567-5769(01)00166-7","volume":"2","author":"T Hirahashi","year":"2002","unstructured":"Hirahashi T, Matsumoto M, Hazeki K, Saeki Y, Ui M, Seya T: Activation of the human innate immune system by spirulina: augmentation of interferon production and NK cytotoxicity by oral administration of hot water extract of Spirulina platensis. Int Immunopharmacol. 2002, 2: 423-34. 10.1016\/S1567-5769(01)00166-7.","journal-title":"Int Immunopharmacol"},{"key":"708_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1055\/s-2001-18358","volume":"8","author":"N Pugh","year":"2001","unstructured":"Pugh N, Ross SA, ElSohly HN, et al: Isolation of three high molecular weight polysaccharide preparations with potent immunostimulatory activity from Spirulina platensis, aphanizomenon flos-aquae and Chlorella pyrenoidosa. Planta Med. 2001, 8: 737-42.","journal-title":"Planta Med"},{"key":"708_CR27","first-page":"114","volume":"2","author":"LP Blinkova","year":"2001","unstructured":"Blinkova LP, Gorobets OB, Baturo AP: Biological activity of Spirulina. Zh Mikrobiol Epidemiol Immunobiol. 2001, 2: 114-8.","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"issue":"5","key":"708_CR28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3177\/jnsv.40.431","volume":"40","author":"O Hayashi","year":"1994","unstructured":"Hayashi O, Katoh T, Okuwaki Y: Enhancement of antibody production in mice by dietary Spirulina platensis. J Nutr Sci Vitaminol. 1994, 40 (5): 431-41. 10.3177\/jnsv.40.431.","journal-title":"J Nutr Sci Vitaminol"},{"issue":"3","key":"708_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0166-3542(02)00132-8","volume":"56","author":"A Hernandez-Corona","year":"2002","unstructured":"Hernandez-Corona A, Nieves I, Meckes M: Antiviral activity of spirulina maxima against herpes simplex virus type 2. Antiviral Res. 2002, 56 (3): 279-85. 10.1016\/S0166-3542(02)00132-8.","journal-title":"Antiviral Res"},{"issue":"3","key":"708_CR30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1006\/eesa.1999.1862","volume":"45","author":"DJ Schaeffer","year":"2000","unstructured":"Schaeffer DJ, Krylov VS: Anti-HIV activity of extracts and compounds from algae and cyanobacteria. Ecotoxicol En Spirulina Saf. 2000, 45 (3): 208-27. 10.1006\/eesa.1999.1862.","journal-title":"Ecotoxicol En Spirulina Saf"},{"issue":"1","key":"708_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1248\/yakushi.128.61","volume":"128","author":"T Hayashi","year":"2008","unstructured":"Hayashi T: Studies on evaluation of natural products for antiviral effects and their applications. Yakugaku Zasshi. 2008, 128 (1): 61-79. 10.1248\/yakushi.128.61.","journal-title":"Yakugaku Zasshi"},{"issue":"15","key":"708_CR32","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1089\/aid.1996.12.1463","volume":"12","author":"K Hayashi","year":"1996","unstructured":"Hayashi K, Hayashi T, Kojima I: A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities. AIDS Res Hum Retroviruses. 1996, 12 (15): 1463-71. 10.1089\/aid.1996.12.1463.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"708_CR33","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.41.7.1521","volume":"41","author":"MR Boyd","year":"1997","unstructured":"Boyd MR, Gustafson KR, McMahon JB, et al: Antimicrob. Agents Chemother. 1997, 41: 1521-30.","journal-title":"Agents Chemother"},{"key":"708_CR34","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1128\/JVI.74.10.4562-4569.2000","volume":"74","author":"B Dey","year":"2000","unstructured":"Dey B, Lerner D, Lusso P, et al: J Virol. 2000, 74: 4562-69. 10.1128\/JVI.74.10.4562-4569.2000.","journal-title":"J Virol"},{"key":"708_CR35","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/JVI.73.5.4360-4371.1999","volume":"73","author":"MT Esser","year":"1999","unstructured":"Esser MT, Mori T, Mondor I, et al: J Virol. 1999, 73: 4360-71.","journal-title":"J Virol"},{"issue":"32","key":"708_CR36","doi-asserted-by":"publisher","first-page":"24845","DOI":"10.1074\/jbc.M110.128546","volume":"285","author":"D Huskens","year":"2010","unstructured":"Huskens D, F\u00e9rir G, Vermeire K, et al: Microvirin, a novel alpha(1,2)-mannose-specific lectin isolated from microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher safety profile. J Biol Chem. 2010, 285 (32): 24845-54. 10.1074\/jbc.M110.128546.","journal-title":"J Biol Chem"},{"issue":"3","key":"708_CR37","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1365-2958.2005.05001.x","volume":"59","author":"JC Kehr","year":"2006","unstructured":"Kehr JC, Zilliges Y, Springer A, et al: A mannan binding lectin is involved in cell-cell attachment in a toxic strain of microcystis aeruginosa. Mol Microbiol. 2006, 59 (3): 893-906. 10.1111\/j.1365-2958.2005.05001.x.","journal-title":"Mol Microbiol"},{"issue":"35","key":"708_CR38","doi-asserted-by":"publisher","first-page":"25177","DOI":"10.1074\/jbc.M602431200","volume":"281","author":"F Helle","year":"2006","unstructured":"Helle F, Wychowski C, Vu-Dac N, et al: Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans. J Biol Chem. 2006, 281 (35): 25177-83. 10.1074\/jbc.M602431200.","journal-title":"J Biol Chem"},{"issue":"1","key":"708_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/095632020701800101","volume":"18","author":"J Balzarini","year":"2007","unstructured":"Balzarini J: Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?. Antivir Chem Chemother. 2007, 18 (1): 1-11.","journal-title":"Antivir Chem Chemother"},{"key":"708_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/gut.45.2.295","volume":"45","author":"ZM Younossi","year":"1999","unstructured":"Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D: Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999, 45: 295-300. 10.1136\/gut.45.2.295.","journal-title":"Gut"},{"key":"708_CR41","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1572-0241.2001.03537.x","volume":"96","author":"ZM Younossi","year":"2001","unstructured":"Younossi ZM, Boparai N, McCormick M, Price LL, Guyatt G: Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol. 2001, 96: 579-583. 10.1111\/j.1572-0241.2001.03537.x.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"708_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/009262300278623","volume":"26","author":"CA McGahuey","year":"2000","unstructured":"McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, Manber R: The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther. 2000, 26 (1): 25-40. 10.1080\/009262300278623.","journal-title":"J Sex Marital Ther"},{"issue":"1-4","key":"708_CR43","first-page":"89","volume":"40","author":"C B\u0103icu\u015f","year":"2002","unstructured":"B\u0103icu\u015f C, T\u0103n\u0103sescu C: Chronic viral hepatitis, the treatment with spiruline for one month has no effect on the aminotransferases. Rom J Intern Med. 2002, 40 (1-4): 89-94.","journal-title":"Rom J Intern Med"},{"issue":"6","key":"708_CR44","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1572-0241.2006.00544.x","volume":"101","author":"A Danoff","year":"2006","unstructured":"Danoff A, Khan O, Wan DW, Hurst L, Cohen D, Tenner CT, Bini EJ: Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life. Am J Gastroenterol. 2006, 101 (6): 1235-43. 10.1111\/j.1572-0241.2006.00544.x.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"708_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/sj.ijir.3901267","volume":"17","author":"A Soykan","year":"2005","unstructured":"Soykan A, Bozta\u015f H, Idilman R, Ozel ET, T\u00fcz\u00fcn AE, Ozden A, Ozden A, Kumbasar H: Sexual dysfunctions in HCV patients and its correlations with psychological and biological variables. Int J Impot Res. 2005, 17 (2): 175-9. 10.1038\/sj.ijir.3901267.","journal-title":"Int J Impot Res"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-12-32\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-32","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T20:19:07Z","timestamp":1593980347000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-12-32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,12]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-12-32","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,12]]},"article-number":"32"}}